Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MLTX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 30, 2026 | MLTX MoonLake Immunotherapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 10, 2026 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 10, 2026 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 15, 2026 | MLTX MoonLake Immunotherapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 25, 2026 | MLTX MoonLake Immunotherapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 22, 2026 | MLTX MoonLake Immunotherapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 22, 2026 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 9, 2026 | MLTX MoonLake Immunotherapeutics | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 9, 2026 | MLTX MoonLake Immunotherapeutics | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 1, 2026 | MLTX MoonLake Immunotherapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 11, 2026 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 11, 2026 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 23, 2026 | MLTX MoonLake Immunotherapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 23, 2026 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 23, 2026 | MLTX MoonLake Immunotherapeutics | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 23, 2026 | MLTX MoonLake Immunotherapeutics | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Feb 23, 2026 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 23, 2026 | MLTX MoonLake Immunotherapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 8, 2026 | MLTX MoonLake Immunotherapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 5, 2025 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2025 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2025 | MLTX MoonLake Immunotherapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 29, 2025 | MLTX MoonLake Immunotherapeutics | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 5, 2025 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 6, 2025 | MLTX MoonLake Immunotherapeutics | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2025 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 29, 2025 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 3, 2025 | MLTX MoonLake Immunotherapeutics | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 3, 2025 | MLTX MoonLake Immunotherapeutics | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Apr 3, 2025 | MLTX MoonLake Immunotherapeutics | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 26, 2025 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 18, 2024 | MLTX MoonLake Immunotherapeutics | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 7, 2024 | MLTX MoonLake Immunotherapeutics | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
34 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:36 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances